Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Havas Lynx explores pharma marketers’ role in addressing climate health crisis
Medical Marketing and Media
Thursday, September 19, 2024 - 11:08am
tags:
Havas Lynx, pharma marketing, climate change
4DMT’S Gene Therapy for AMD Clears Phase II, Heads to Late-Stage Studies
BioSpace
Thursday, September 19, 2024 - 11:07am
tags:
4DMT, gene therapy, AMD, clinical trials, wet age-related macular degeneration
Navigating the AI 'hype cycle': Bayer, Daiichi Sankyo and argenx leaders on implementing AI in biopharma marketing
Fierce Pharma
Thursday, September 19, 2024 - 11:06am
tags:
artificial intelligence, Bayer, Daiichi Sankyo, Argenx
Starton successfully delivers cancer drug using on-body injector
Clinical Trials Arena
Thursday, September 19, 2024 - 11:05am
tags:
Starton Therapeutics, lenalidomide, cancer, drug delivery, on-body injector
Vanda receives FDA rejection, issues fiery response against ‘conclusory’ refusal
Fierce Biotech
Thursday, September 19, 2024 - 9:29am
tags:
Vanda Pharmaceuticals, FDA, gastroparesis, clinical trials, tradipitant
Cercle secures $6M seed fundraise to advance women’s healthcare
Businesswire
Thursday, September 19, 2024 - 9:27am
tags:
Cercle, funding, artificial intelligence, Women's Health
Roche reports positive data from Phase III influenza treatment trial
Clinical Trials Arena
Thursday, September 19, 2024 - 9:24am
tags:
Roche, Flu, clinical trials, Xofluza
FDA inspection backlog overseas threatens new drug approvals
Pharma Voice
Thursday, September 19, 2024 - 9:23am
tags:
FDA, regulatory inspections, regulatory, drug approvals
At J&J, oncology R&D meets commercial strategy in a quest for new standards of care
Pharma Voice
Thursday, September 19, 2024 - 9:22am
tags:
JNJ, R&D, oncology
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
Pharmaphorum
Thursday, September 19, 2024 - 9:21am
tags:
GSK, COPD, ICER, drug pricing, Medicare
FDA Approves Merck’s Keytruda for First-Line Treatment of Pleural Mesothelioma
BioSpace
Wednesday, September 18, 2024 - 11:16pm
tags:
Merck, Keytruda, mesothelioma, FDA
Fresenius Kabi Ivenix Pump Sees Second Recall in 2024
Medical Devices and Diagnostics Industry
Wednesday, September 18, 2024 - 11:13pm
tags:
Medtech, Fresenius Kabi, device recalls, Ivenix Infusion Pump LVP
Respiratory disorder biotech Upstream Bio files for a $100 million IPO
Renaissance Capital
Wednesday, September 18, 2024 - 11:10pm
tags:
Upstream Bio, monoclonal antibodies, IPOs, Respiratory
Masimo's Fate To Be Decided Thursday
Medical Devices and Diagnostics Industry
Wednesday, September 18, 2024 - 11:08pm
tags:
Masimo, Medtech, Politan Capital
Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic
Reuters
Wednesday, September 18, 2024 - 11:05pm
tags:
GAVI, Bavarian Nordic, mpox, vaccines
FDA Approves Fasenra for Treatment of Eosinophilic Granulomatosis with Polyangiitis
Managed Healthcare Executive
Wednesday, September 18, 2024 - 11:03pm
tags:
AstraZeneca, Fasenra, eosinophilic granulomatosis with polyangiitis
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
Fierce Biotech
Wednesday, September 18, 2024 - 1:56pm
tags:
Applied Therapeutics, govorestat, FDA, Rare Diseases
Ascendis trial data piles pressure on BioMarin
BioPharma Dive
Wednesday, September 18, 2024 - 1:42pm
tags:
Ascendis Pharma, Biomarin, Voxzogo, achondroplasia
Organon pays up to $1.2B to acquire Dermavant and its steroid-free skin cream Vtama
Fierce Pharma
Wednesday, September 18, 2024 - 1:39pm
tags:
Organon, Roivant, Dermavant, M&A, immuno-dermatology
ESMO: Innovent links cytokine fusion protein to responses in colorectal cancer
Fierce Biotech
Wednesday, September 18, 2024 - 1:38pm
tags:
Innovent Biologics, cytokine fusion protein, colorectal cancer, clinical trials

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.